Solara Active Pharma Sciences: Conversion of Partly Paid-Up Rights Shares into Fully Paid-Up Equity Shares

Regulatory 19 Aug 2026 · In force· ✓ Verified

Solara Active Pharma Sciences Limited, a manufacturer of active pharmaceutical ingredients (APIs) and specialty chemicals, conducted a rights issue offering partly paid-up equity shares to shareholders. Upon receipt of call monies from subscribers, the company converted those partly paid-up shares into fully paid-up equity shares, a mandatory step under the allotment and call mechanism. The conversion was reported to the National Stock Exchange (NSE) as a regulatory update on 19 August 2026. This is a standard post-rights-issue compliance filing, not a funding event itself.

Why it mattersRights issue conversions are mechanical post-allotment events triggered by receipt of call money; the structuring and gating occurred at issue launch, not here-this disclosure reflects completion of the subscription mechanism.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals